ARCC:晚期肾细胞癌
“晚期肾细胞癌”(Advanced Renal Cell Carcinoma)在医学和临床研究领域常缩写为ARCC,以方便在文献、诊断记录和交流中快捷书写和使用。该术语广泛出现在肿瘤学、药物研发及相关综合领域,尤其是在未分类或泛指的临床资料中,用于指代肾细胞癌的进展阶段。
Advanced Renal Cell Carcinoma具体释义
Advanced Renal Cell Carcinoma的英文发音
例句
- Sorafenib is currently approved in the United States and other countries for treatment of advanced renal cell carcinoma.
- 当前索拉非尼在美国和其他国家被批准用来治疗晚期肾细胞癌(ARCC)。
- Biotherapy is an effective treatment strategy for advanced renal cell carcinoma.
- 生物治疗是治疗晚期肾癌的有效方法。
- Conclusion Recombinant interferon α 2b has antitumor activity in patients with advanced renal cell carcinoma, malignant melanoma and malignant lymphoma. It could be considered as a second line treatment regimen.
- 结论r-IFNα-2b具有一定抗肿瘤活性,可以将其作为第二线药物治疗肾癌、黑色素瘤及恶性淋巴瘤。
- Efficacy of activated haploidentical allogeneic hematopoietic stem cells on advanced intractable renal cell carcinoma
- 活化单倍相合异基因造血干细胞治疗晚期难治性肾癌的疗效观察
- Biological treatment can take some effect in patients with the advanced stage renal cell carcinoma.
- 联合生物治疗对晚期肾癌患者有一定效果。
本站英语缩略词为个人收集整理,可供非商业用途的复制、使用及分享,但严禁任何形式的采集或批量盗用
若ARCC词条信息存在错误、不当之处或涉及侵权,请及时联系我们处理:675289112@qq.com。